"Control4 is making home automation a reality with a unique line of wired and wireless home automation products," said Grosser. "At Foundation Capital, we believe the market for digital home products is on the verge of explosive growth, and Control4 has the management team, products and market position to take advantage of this important market."
“We are pleased that customers, partners and investors are responding to our value proposition of delivering affordable, easy-to-use home automation solutions to a broad consumer market. This latest round of funding from outstanding investment partners allows Control4 to continue building on its momentum.”
Control4, which began shipping products in April of this year, is the first to deliver 802.15.4 (ZigBee) wireless products that can be retrofitted into any home to provide reliable, cost-effective home control. The company will be showcasing its award-winning home automation products and services at the CEDIA trade show in September.
"Since we started shipping products in April, the demand has exceeded our already high expectations," said Will West, chief executive officer, Control4. "We are pleased that customers, partners and investors are responding to our value proposition of delivering affordable, easy-to-use home automation solutions to a broad consumer market. This latest round of funding from outstanding investment partners allows Control4 to continue building on its momentum."
About Control4
Control4 makes home automation and control a practical option for any home by combining innovative technology with today's wired and wireless networking standards. From home theater control, to complete music and lighting management in every room, Control4 products provide lifestyle benefits previously available only in luxury homes. The company is delivering tomorrow's lifestyle today by providing a new breed of home automation solutions that are affordable, modular and easy to use. The company is headquartered in Salt Lake City. For more information, please visit www.control4.com.
About Foundation Capital
Founded in 1995, Foundation Capital is a venture capital firm committed to supporting entrepreneurs and their companies, targeting innovative opportunities in telecommunications and networking; Internet infrastructure; and enterprise software. Foundation Capital funds total more than $1.1 billion and include Harvard, Yale, CalTech, the Hewlett Foundation, and MacArthur Foundation as investors. For more information, visit www.foundationcapital.com.
About Frazier Technology Ventures
Frazier Technology Ventures (FTV) is a Seattle-based, early-stage venture capital firm focused on wireless, communications, media and enterprise technologies. The partnership has deep, executive operating background from ATT, CCube, Immunex, LSILogic, Microsoft, RealNetworks, Visio and other successful startups. FTV is part of 13-year-old Frazier Healthcare and Technology Ventures and has more than $1.3 billion in capital under management.
About Thomas Weisel Venture Partners
Thomas Weisel Venture Partners (TWVP) is an early-stage venture capital firm that invests in emerging information technology companies. As a partner with a long-term perspective, TWVP plays an active role in helping entrepreneurs turn ideas into sustainable businesses. TWVP portfolio companies benefit from the knowledge, energy and resources of the TWVP team and from TWVP's commitment to working with management to build industry-leading companies. TWVP was founded in 2000 in partnership with Thomas Weisel Partners, a San Francisco-based merchant bank, and is located in E. Palo Alto, Calif. For more information, visit www.twvp.com.
About vSpring Capital
vSpring is a traditional early-stage venture capital firm with more than $180 million of committed capital under management. The firm specifically targets information technology and life sciences companies headquartered in the Intermountain West region. Its primary areas of focus include enterprise software, networking and communications, security software, Internet, mobile computing, drug discovery, drug delivery, diagnostics, and medical devices, all markets where the firm has deep experience.
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
